22nd Century Group Inc Sells GVB Biopharma for $2.25 Million

Business by 2FIRSTS.ai
Nov.29.2023
22nd Century Group Inc Sells GVB Biopharma for $2.25 Million
US cigarette manufacturer, 22nd Century Group Inc, has sold its cannabis subsidiary, GVB Biopharma, for $2.25 million, exiting the industry after less than 18 months.

According to a report by Journalnow on November 29, American cigarette manufacturer 22nd Century Group Inc has announced the sale of its cannabis subsidiary, GVB Biopharma, for a sum of $2.25 million. This move signifies the company's formal exit from the cannabis industry, which proved to be a significant financial burden in less than a year and a half.

 

According to regulatory documents released on Monday, the purchaser of GVB is Specialty Acquisition Corp, a professional acquisition company based in Nevada.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.
Nov.18 by 2FIRSTS.ai
COP11 Concludes with Major Decisions on Global Tobacco Control
COP11 Concludes with Major Decisions on Global Tobacco Control
The Eleventh Session of the Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on November 22, with 160 Parties adopting major decisions on tobacco and nicotine regulation, environmental protection, sustainable financing, and tobacco industry liability. A landmark decision mandates a complete ban on the use and sale of tobacco and all novel nicotine products across all UN premises worldwide.
Nov.24 by 2FIRSTS.ai
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police said officers expanded an investigation into a major e-cigarette smuggling network in the South and arrested a 23-year-old woman at Hat Yai Junction railway station on Jan. 6, 2026.
Jan.08 by 2FIRSTS.ai
Product | Compatible with Terea Sticks and Supporting Dual Heating: HiTaste Unveils New Heated Tobacco Device
Product | Compatible with Terea Sticks and Supporting Dual Heating: HiTaste Unveils New Heated Tobacco Device
HiTaste has introduced its new HNB device, the F10, on social media, highlighting its wrap-around heating and dual-heating features. Similar “dual-heating” and “one-stick-two-sessions” designs were widely showcased at InterTabac 2025, signaling that this technical direction is emerging as a new competitive focus among HNB brands.
Nov.17 by 2FIRSTS.ai
Pakistan Senate bill seeks strict control of vapes and e-cigarettes in Islamabad, including under-18 sales ban
Pakistan Senate bill seeks strict control of vapes and e-cigarettes in Islamabad, including under-18 sales ban
Following approval by the Senate Standing Committee on National Health Services, the Electronic Nicotine Delivery Systems (Regulation) Bill is set to be tabled in the Senate to impose strict controls on the sale, marketing and use of vapes and e-cigarettes in Islamabad.
Jan.08 by 2FIRSTS.ai